Home
Research
Submit Article
News
Sectors
Advertise
Premium
i On The Market - Daily Newsletter
Every trading day, be ready to attack the market instead of reacting to the market.
You will know where the key technical resistance and support levels are and what the market is likely to do next. iStock will arm you with a target list of stocks to buy and sell - right now - based on our exclusive, proprietary trading models.
Two Week FREE Trial
About Us
About Us
Editorial Staff
Terms and Conditions
Privacy Policy
Contact Us
iStock Rating
B
Details...
Enter Symbol
Lehman ABS Corporation (NYSE: BMY)
Sector: Medical
Current Price :
$46.85
52 Week Low
$30.81
52 Week High
$47.68
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
1642M
Market Cap:
$76.87B
Avg Volume:
12233586
P/E Ratio:
27.050
PEG Ratio:
5.640
Split:
On 3/1/1999 bmy split by factor of 2.000
Opinion and Analysis
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE) and Bristol Myers Squibb Co. (BMY) : The Rebound May Be Over For Big Pharma
Jun 11, 2013 06:50 PM |
BMY
,
LLY
,
MRK
,
NVS
,
PFE
,
RHHBY
Novo Nordisk A/S (ADR) (NVO): Has One Of The Widest Moats In Health Care
Jun 06, 2013 04:25 PM |
AZN
,
BMY
,
MRK
,
NVO
Johnson & Johnson (JNJ) - A Must Own Dividend Stock
May 31, 2013 10:03 AM |
BMY
,
JNJ
,
NVS
,
PFE
More Articles on BMY..
Press Releases
Bristol-Myers Squibb Grants Help K-12 Educators Bring Science to Life and Help Students Explore Their Interests in the Sciences and Science-Based Careers
Jun 18, 2013 09:00 AM |
BMY
Key to Success, How to Profit: FSLR, NWSA, BMY and LULU
Jun 18, 2013 08:00 AM |
BMY
,
FSLR
,
LULU
Litigation Settlements, Data Compliance Reviews, and Clinical Trials Pave Way for Solid Footing in Healthcare - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Keryx and Pacira Pharmaceuticals
Jun 17, 2013 08:00 AM |
BMY
,
KERX
,
MRK
,
PFE
More Press Releases on BMY..
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
BMY
Compare to S&P
YTD
43.60 %
25.90 %
4 Weeks
8.08 %
10.79 %
12 Weeks
15.87 %
10.90 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-12.77 %
EPS Growth in Last Year:
-35.94 %
Sales Growth in Last Quarter:
-8.59 %
Sales Growth in Last Quarter:
-27.04 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##